Status:
COMPLETED
A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
University of Massachusetts, Worcester
Conditions:
Osteoporosis
Eligibility:
FEMALE
55+ years
Phase:
NA
Brief Summary
The purpose of this study is to conduct a randomized trial of a tailored intervention designed to provide personalized feedback regarding patients' risk of subsequent fractures, customized information...
Eligibility Criteria
Inclusion
- Self-reported history of fracture
Exclusion
- Self-reported current prescription osteoporosis treatment
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
2684 Patients enrolled
Trial Details
Trial ID
NCT01907269
Start Date
August 1 2013
End Date
November 1 2016
Last Update
June 26 2018
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35205
2
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
3
University of Massachusetts at Worcester
Worcester, Massachusetts, United States, 01655
4
New York University
New York, New York, United States, 10016